AKAnna Karcz

Anna Karcz

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Anna Karcz has a total of 9 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    SEMAGLUTIDE IN OBESITY AND EXERCISE MEDICINE: A REVIEW OF CLINICAL EVIDENCE, PERFORMANCE IMPLICATIONS, AND IMPLEMENTATION CHALLENGES

    by Aleksandra Romaniuk, Sofiya Salash, Artur Koza, Anna Karcz, Barbara Pająk, Hubert Bołdys-Żegocki, Jakub Majewski, Maria Kaniecka, Małgorzata Dworniczak, Oliwia Wróblewska

    Background. Obesity is a growing global public health issue. Semaglutide (Ozempic), a glucagon-like peptide-1 receptor agonist (GLP-1 RA), represents a breakthrough in obesity pharmacotherapy, with documented benefits in weight reduction, metabolic control, and cardiovascular risk reduction. Aim. To review key clinical evidence on semaglutide in obesity treatment, explain its mechanism of action, and discuss practical aspects of implementing semaglutide therapy in Poland, including accessibility and long-term use, with particular emphasis on integration with physical activity and rehabilitation. Material and methods. The article is based on a narrative synthesis of existing sources, including key clinical trials, meta-analyses, international recommendations, and Polish regulatory and reimbursement documents concerning semaglutide use in obesity. Conclusions. Semaglutide is an effective and innovative pharmacological option in obesity management, with additional potential benefits for physical activity tolerance and weight-related rehabilitation in both recreationally active and sedentary individuals. Optimal long-term outcomes require combining semaglutide therapy with comprehensive lifestyle interventions, particularly structured exercise programs, while addressing challenges of accessibility and long-term treatment in Poland.

  • Open Access

    TESTOSTERONE REPLACEMENT THERAPY IN MEN WITH HYPOGONADISM – REVIEW OF LITERATURE

    by Jakub Majewski, Oliwia Wróblewska, Maria Kaniecka, Anna Karcz, Barbara Pająk, Małgorzata Dworniczak, Sofiya Salash, Aleksandra Romaniuk, Hubert Bołdys-Żegocki, Artur Koza

    Testosterone replacement therapy (TRT) is the fundamental intervention in the treatment of male hypogonadism. Despite many years of clinical experience, in recent years the benefits and risks of TRT have been intensely discussed. The aim of this review article is to summarize the current state of knowledge on the pathophysiology of hypogonadism, diagnostic criteria, indications and effects of therapy, taking into account different patient groups. An analysis of available scientific publications was conducted, including clinical trials, meta-analyses, and official expert guidelines. The results of the review indicate that testosterone therapy significantly improves sexual function in men (including libido and erection) and has a beneficial effect on well-being. An increase in muscle mass, improvement in body composition (increase in lean mass and reduction of visceral fat), and also an increase in bone mineral density were observed. At the same time, attention is drawn to possible adverse effects of TRT, such as the development of polycythemia (elevated hematocrit), inhibition of sperm production, and potential exacerbation of obstructive sleep apnea symptoms in some patients. Testosterone therapy can bring significant benefits in the treatment of hypogonadism, especially in terms of improving sexual function and overall quality of life. However, the choice of treatment should be tailored to the patient in each case, taking into account possible risks, such as cardiovascular risk or impact on fertility. Due to remaining uncertainties, further prospective studies are necessary to more precisely assess the long-term safety of testosterone therapy.

  • Open Access

    EVALUATING THE SAFETY OF HOME BIRTH IN THE MODERN HEALTHCARE CONTEXT: EVIDENCE FROM INTERNATIONAL RESEARCH

    by Maria Kaniecka, Anna Karcz, Barbara Pająk, Oliwia Wróblewska, Małgorzata Dworniczak, Sofiya Salash, Aleksandra Romaniuk, Jakub Majewski, Hubert Bołdys-Żegocki, Artur Koza

    The choice between home birth and hospital birth remains a topic of considerable discussion within contemporary obstetrics. The choice of birth setting and the characteristics of women opting for home birth vary across different regions of the world. In developed countries, hospitals are the default place of birth, whereas in developing countries, childbirth more often occurs at home. One of the most important criteria for comparing home and hospital births is the safety of both the mother and the newborn. The comparison of home and hospital births among low-risk women shows similar neonatal safety, with lower NICU (Neonatal Intensive Care Unit) admissions and intervention rates in home births. Mothers delivering at home experience fewer cesarean sections, episiotomies, and postpartum complications. However, outcomes vary regionally, with U.S. studies reporting higher neonatal risks in planned home births. Transfer to hospital rates range from 10-30%, mainly due to slow labour. VBACs (Vaginal Birth After Cesarean) at home are associated with lower cesarean rates but higher non-urgent transfers. Postpartum outcomes, including breastfeeding success, are superior after home birth. Evidence suggests that, in integrated systems, home birth can be a safe and informed choice.

  • Open Access

    WHEN COPD ISN’T COPD: A FOURTEEN-YEAR CASE STUDY OF ADULT-ONSET SWYER-JAMES-MACLEOD SYNDROME

    by Małgorzata Dworniczak, Maria Kaniecka, Anna Karcz, Barbara Pająk, Oliwia Wróblewska, Sofiya Salash, Aleksandra Romaniuk, Jakub Majewski, Hubert Bołdys-Żegocki, Artur Koza

    Swyer-James-MacLeod (SJML) syndrome, also known as unilateral hyperlucent lung syndrome, is a rare post-infectious pulmonary disorder characterized by emphysematous changes, unilateral pulmonary artery hypoplasia, and regional hypoperfusion [1, 2]. The hallmark radiographic feature - often referred to as the “hyperlucent lung” or “clear lung sign” - reflects air trapping with decreased vascular markings and serves as the signature diagnostic clue of this condition [3, 6]. SJML syndrome typically develops following childhood bronchiolitis or pneumonitis but may remain unrecognized until adulthood due to its nonspecific respiratory presentation [4, 7]. We report the case of a 41-year-old woman who has been under observation and treatment for the past 14 years. Despite chronic, non-productive cough and persistent unilateral pulmonary abnormalities, she was not initially diagnosed with SJML syndrome due to the absence of standardized diagnostic criteria. Radiological assessment, including high-resolution computed tomography (HRCT) and CT angiography, revealed a hyperlucent and volume-reduced left lung with bronchiectasic changes and pulmonary arterial hypoplasia, findings consistent with described syndrome. Pulmonary function tests demonstrated moderate airflow obstruction, while the patient’s prolonged childhood exposure to tobacco smoke may have contributed to airway remodeling. This long-term follow-up highlights the diagnostic importance of recognizing unilateral hyperlucency as the signature sign of SJML syndrome and underscores the need for multidisciplinary monitoring to optimize long-term respiratory outcomes [5–7].

  • Open Access

    NUTRITIONAL AND ENVIRONMENTAL FACTORS DETERMINING DHA STATUS IN PREGNANT AND LACTATING WOMEN: IMPLICATIONS FOR MATERNAL AND NEONATAL HEALTH

    by Anna Karcz, Maria Kaniecka, Barbara Pająk, Oliwia Wróblewska, Małgorzata Dworniczak, Sofiya Salash, Aleksandra Romaniuk, Jakub Majewski, Hubert Bołdys-Żegocki, Artur Koza

    The intake of omega-3 polyunsaturated fatty acids, particularly docosahexaenoic acid (DHA), is essential for the proper development of the fetus and for maintaining the health and well-being of the pregnant woman, as well as of both the mother and the infant during the lactation period. Numerous studies have demonstrated the beneficial effects of DHA on the development of the nervous system and retinal function, as well as its role in reducing the risk of preeclampsia, preterm delivery, low birth weight, postpartum depression, perinatal maternal mortality, and neonatal intensive care unit admissions. Moreover, DHA has been shown to positively influence the clinical course of certain neonatal disorders after birth. Available data suggest that the dietary and supplemental intake of DHA among pregnant women in Poland may be insufficient compared with current nutritional recommendations. The richest dietary sources of DHA include fatty fish and seafood; however, it is advisable to select species with the lowest levels of methylmercury contamination. Storage and thermal processing affect the omega-3 content in food. Vegetarian women may be particularly susceptible to DHA deficiency. Dietary supplementation with DHA derived from controlled microalgae cultures or fish oils can effectively compensate for inadequate intake. Maintaining an appropriate balance between omega-3 and omega-6 fatty acid consumption is crucial. It is also hypothesized that eicosapentaenoic acid (EPA) may be required for the efficient utilization of DHA by the fetus and may contribute to a reduced risk of preterm birth and preeclampsia. Consumption of DHA increases the risk of macrosomia in the fetus and may influence the extension of pregnancy beyond 42 weeks.

  • Open Access

    NUTRITIONAL FACTORS AND THEIR ROLE IN MENTAL HEALTH - A CLINICAL REVIEW

    by Oliwia Wróblewska, Jakub Majewski, Barbara Pająk, Maria Kaniecka, Anna Karcz, Artur Koza, Hubert Bołdys-Żegocki, Małgorzata Dworniczak, Sofiya Salash, Aleksandra Romaniuk

    The aim of this study was to review the current scientific evidence on the effects of selected nutrients on mental health in the general population. Randomized controlled trials, metaanalyses, and systematic reviews published between 2018 and 2025 were analyzed, retrieved from the PubMed, Embase, and Google Scholar databases. The review considered associations between the intake of omega-3 fatty acids, B-group vitamins, vitamin D, zinc, magnesium, probiotics, prebiotics, and antioxidants (vitamins C, E, carotenoids, and polyphenols) and the occurrence of depressive, anxiety, and cognitive symptoms. Literature data indicate that deficiencies of these nutrients may affect neurotransmitter function, neuronal plasticity, inflammatory processes, and oxidative stress, linking diet to the pathophysiological mechanisms of mood disorders. Supplementation with omega-3 fatty acids, folic acid, magnesium, zinc, vitamin D, and selected probiotics demonstrated moderate improvement in mood and reduction of anxiety symptoms in most analyzed studies, while the results for vitamins C, E, and B₁₂ remain inconclusive. Beneficial effects of curcumin and βcarotene were also observed in reducing oxidative stress and improving psychological wellbeing. The collected data suggest that an adequate supply of micronutrients and antiinflammatory components may support mental health, but the current evidence is limited by small sample sizes, short observation periods, and heterogeneity of interventions. In clinical practice, a balanced diet remains essential, while supplementation should be individualized and applied in cases of confirmed deficiency. This article summarizes the current state of knowledge and indicates directions for future research.

  • Open Access

    STRESS, PERSONALITY AND MIGRAINE. A REVIEW OF PSYCHOSOCIAL AND NEUROPHYSIOLOGICAL RISK FACTORS

    by Sofiya Salash, Aleksandra Romaniuk, Artur Koza, Anna Karcz, Barbara Pająk, Hubert Bołdys-Żegocki, Jakub Majewski, Maria Kaniecka, Małgorzata Dworniczak, Oliwia Wróblewska

    Migraine is a complex neurological and psychological condition that causes repeated headache attacks, sensitivity to light and sound, and major effects on quality of life. Modern research shows that migraine develops from the interaction between biological sensitivity, stress, and personality traits. This review combines findings from neuroscience, psychology, and clinical studies to explain how stress reactivity, emotional regulation, and coping style affect migraine onset and management. Understanding these biological and psychosocial links can improve treatment and support more effective combined approaches that use both medication and psychotherapy.

  • Open Access

    Comparison of the long-term clinical, metabolic, and economic outcomes of sleeve gastrectomy (SG) and roux-en-y gastric bypass (RYGB)

    by Hubert Bołdys-Żegocki, Anna Karcz, Barbara Pająk, Oliwia Wróblewska, Małgorzata Dworniczak, Sofiya Salash, Aleksandra Romaniuk, Jakub Majewski, Maria Kaniecka, Artur Koza

    Introduction: Obesity is a chronic, multifactorial disease affecting over one billion people worldwide (WHO, 2025). It increases the risk of type 2 diabetes, cardiovascular diseases and certain cancers. Because conservative treatment has limited long-term efficacy, bariatric surgery, particularly Sleeve Gastrectomy (SG) and Roux-en-Y Gastric Bypass (RYGB), has become a key therapy for morbid obesity.Aim: To compare long-term clinical, metabolic and cost-effectiveness outcomes of SG and RYGBMaterials and Methods: A literature review was conducted using PubMed, PMC, Google Scholar and ResearchGate, limited to English publications. The analysis included major randomized trials and cost-effectiveness studies, as well as WHO, IFSO and national guidelines.Results: RYGB produced greater long-term weight loss, with %TWL higher by 3.6–4.9 percent, and higher diabetes remission (75 vs 61 percent at 1 year; 37 vs 27 percent at 10 years) compared with SG. It also more strongly improved insulin sensitivity and triglycerides, but carried an increased risk of nutritional deficiencies, mainly iron and vitamin B12, requiring lifelong supplementation. SG caused fewer nutritional issues but was associated with a higher incidence of GERD. Quality-of-life improvements measured by SF-36 and BAROS were similar. Cost analyses showed that RYGB, despite higher initial costs, leads to net savings within 5–10 years because of greater remission of metabolic comorbidities. Both Borisenko and Lauren confirmed its economic advantage in public health systems.Conclusions: RYGB offers superior long-term metabolic benefits and cost-effectiveness, though with higher nutritional risk. SG remains a safe and effective option, especially for patients without severe metabolic disease or GERD. The choice of procedure should be individualized, considering metabolic benefit, nutritional risk and economic factors.